All these results indicate that RALYL could upregulate the expression of stemness-related markers; increase stemness properties of HCC, including tumorigenicity, self-renewal, chemoresistance, and maintain HCC cells in a poor differentiation state. Here, RALYL is linked to hepatocellular carcinoma.